Last reviewed · How we verify
Hyperammonemia associated with N-acetylglutamate synthase deficiency
Approved treatments
- Carbaglu · Recordati
Carbaglu works by activating the enzyme carbamoyl phosphate synthetase 1, which helps regulate ammonia levels in the body. - Carbaglu · Mendel Tuchman
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hyperammonemia associated with N-acetylglutamate synthase deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Hyperammonemia associated with N-acetylglutamate synthase deficiency treatment landscape brief
- Hyperammonemia associated with N-acetylglutamate synthase deficiency treatment updates RSS
Frequently asked questions about Hyperammonemia associated with N-acetylglutamate synthase deficiency
What drugs treat Hyperammonemia associated with N-acetylglutamate synthase deficiency?
Tracked treatments include Carbaglu.
What is the treatment for Hyperammonemia associated with N-acetylglutamate synthase deficiency?
Standard treatment for Hyperammonemia associated with N-acetylglutamate synthase deficiency includes Carbaglu. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hyperammonemia associated with N-acetylglutamate synthase deficiency patent cliff · Hyperammonemia associated with N-acetylglutamate synthase deficiency CI report
- Treatment: Carbaglu · Recordati
- Treatment: Carbaglu · Mendel Tuchman
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing